Le Lézard
Classified in: Health
Subjects: TDS, BFA

CERAGEM Steals the Show at CES 2024 with Innovative Home Health Solutions


Attendees, Including Legendary Stevie Wonder, at the Largest Technology Showcase in the World Awed by Award-Winning Home Healthcare Products

LAS VEGAS, Jan. 12, 2024 /PRNewswire/ -- At CES 2024, the world's most influential tech event, CERAGEM Co. Ltd. has captivated attendees with innovative home health solutions. Celebrating its 25th anniversary, the company has drawn significant attention with its flagship store in West Hollywood, CA, becoming a focal point for wellness technology.

The CERAGEM booth has been buzzing with activity, as attendees experience firsthand the benefits of the company's spinal therapy and wellness products. Visitors, impressed by the efficacy and design of products like the V7 and V9 massage beds, and the PRIME S4 and PAUSE series massage chairs, left the booth invigorated and more informed about their health and wellness options.

Music icon Stevie Wonder also visited CERAGEM's booth, where he tested and expressed his admiration for their home healthcare products. His visit underscores the universal appeal of CERAGEM's innovations in wellness technology.

While CERAGEM's receipt of three CES Innovation Awards has been a highlight, the focus of its booth has been on engaging with visitors and demonstrating the practicality and effectiveness of their products. Positive reactions from CES attendees are a testament to CERAGEM's commitment to blending form with function, creating devices that are as aesthetically pleasing as they are beneficial for healthcare at home.

Looking forward, CERAGEM is poised to strengthen its presence in the U.S. market with aggressive marketing strategies and a focus on customer-centric innovations. This approach is expected to solidify CERAGEM's position as a leading provider of home healthcare solutions, making advanced, hospital-grade devices accessible and practical for home use.

About CERAGEM Co. Ltd.

For over 25 years, CERAGEM has redefined home healthcare. From pioneering thermotherapy beds to innovative devices for sleep, pain relief, beauty, and mindfulness, CERAGEM brings total wellness to your fingertips. With community programs in over 70 countries, CERAGEM is more than a brand - it's on a global mission to empower health and happiness at home. Experience relaxation, rejuvenation, and the future of well-being at a CERAGEM Well Cafe. For more information, visit: www.CERAGEMus.com

SOURCE CERAGEM Co., Ltd.


These press releases may also interest you

at 19:35
CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER
CV Sciences, Inc.  (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has consummated...

at 19:32
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy
Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that the first patients with diabetic retinopathy...

at 19:21
Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies
Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need, today announced that the Center for Drug...

at 18:30
Cannabix Technologies Enters into Marketing Agreements  
Cannabix Technologies Inc. (the "Company or Cannabix") reports that it has entered into an arm's length marketing agreements with the following parties: Effective May 13, 2024, the Company has engaged Financial Buzz Media Networks LLC ("FBMN") for...

at 18:25
Pint Pharma Announces the Approval of ORLADEYO® (berotralstat), the First Oral Therapy Indicated for Preventing Hereditary Angioedema (HAE) Attacks in Adult and Pediatric Patients Aged 12 and Older in Mexico
It is with great pleasure that we announce the Federal Commission for Protection against Health Risks (COFEPRIS) in Mexico has granted approval for oral, once-daily ORLADEYO® (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks...

at 18:03
Kelyniam Global Releases Q1 Financials
Kelyniam Global , a maker of custom cranial implants, today announced results for its quarter ended March 31, 2024.  Financial highlights for the three months ended March 31, 2024 and the same period in 2023 include:  Total revenue of $957,447...

More news about Health...


News published on and distributed by: